feed,title,long_url,short_url
Benzinga,Sanofi-AstraZeneca's Nirsevimab Hits Primary Endpoint Goal In Late-Stage RSV Disease In Infants,https://benzinga.com/general/biotech/21/04/20786270/sanofi-astrazenecas-nirsevimab-hits-primary-endpoint-goal-in-late-stage-rsv-disease-in-infants,https://j.mp/3gzu7NM
Benzinga,ADC Therapeutics Stock Jumps On Scoring First FDA Approval For DLBCL Treatment,https://benzinga.com/general/biotech/21/04/20786142/adc-therapeutics-stock-jumps-on-scoring-first-fda-approval-for-dlbcl-treatment,https://j.mp/3xzYSs2
